PMID- 25150299 OWN - NLM STAT- MEDLINE DCOM- 20150303 LR - 20210202 IS - 1528-0020 (Electronic) IS - 0006-4971 (Linking) VI - 124 IP - 15 DP - 2014 Oct 9 TI - Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4. PG - 2442-9 LID - 10.1182/blood-2014-03-559518 [doi] AB - The chemokine platelet factor 4 (PF4) undergoes conformational changes when complexing with polyanions. This can induce the antibody-mediated adverse drug effect of heparin-induced thrombocytopenia (HIT). Understanding why the endogenous protein PF4 becomes immunogenic when complexing with heparin is important for the development of other negatively charged drugs and may also hint toward more general mechanisms underlying the induction of autoantibodies to other proteins. By circular dichroism spectroscopy, atomic force microscopy, and isothermal titration calorimetry we characterized the interaction of PF4 with unfractionated heparin (UFH), its 16-, 8-, and 6-mer subfractions, low-molecular-weight heparin (LMWH), and the pentasaccharide fondaparinux. To bind anti-PF4/heparin antibodies, PF4/heparin complexes require (1) an increase in PF4 antiparallel beta-sheets exceeding approximately 30% (achieved by UFH, LMWH, 16-, 8-, 6-mer), (2) formation of multimolecular complexes (UFH, 16-, 8-mer), and (3) energy (needed for a conformational change), which is released by binding of >/=11-mer heparins to PF4, but not by smaller heparins. These findings may help to synthesize safer heparins. Beyond PF4 and HIT, the methods applied in the current study may be relevant to unravel mechanisms making other endogenous proteins more vulnerable to undergo conformational changes with little energy requirement (eg, point mutations and post-translational modifications) and thereby predisposing them to become immunogenic. CI - (c) 2014 by The American Society of Hematology. FAU - Kreimann, Martin AU - Kreimann M AD - ZIK HIKE-Zentrum fur Innovationskompetenz, Humorale Immunreaktionen bei Kardiovaskularen Erkrankungen, Greifswald, Germany; FAU - Brandt, Sven AU - Brandt S AD - ZIK HIKE-Zentrum fur Innovationskompetenz, Humorale Immunreaktionen bei Kardiovaskularen Erkrankungen, Greifswald, Germany; FAU - Krauel, Krystin AU - Krauel K AD - Institut fur Immunologie und Transfusionsmedizin, Greifswald, Germany; FAU - Block, Stephan AU - Block S AD - ZIK HIKE-Zentrum fur Innovationskompetenz, Humorale Immunreaktionen bei Kardiovaskularen Erkrankungen, Greifswald, Germany; FAU - Helm, Christiane A AU - Helm CA AD - Institut fur Physik, Greifswald, Germany; and. FAU - Weitschies, Werner AU - Weitschies W AD - Institut fur Pharmazie, Greifswald, Germany. FAU - Greinacher, Andreas AU - Greinacher A AD - Institut fur Immunologie und Transfusionsmedizin, Greifswald, Germany; FAU - Delcea, Mihaela AU - Delcea M AD - ZIK HIKE-Zentrum fur Innovationskompetenz, Humorale Immunreaktionen bei Kardiovaskularen Erkrankungen, Greifswald, Germany; LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140822 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Antibodies) RN - 0 (Heparin, Low-Molecular-Weight) RN - 0 (Polysaccharides) RN - 37270-94-3 (Platelet Factor 4) RN - J177FOW5JL (Fondaparinux) SB - IM MH - Antibodies/*metabolism MH - Calorimetry MH - Circular Dichroism MH - Enzyme-Linked Immunosorbent Assay MH - Fondaparinux MH - Heparin, Low-Molecular-Weight/chemistry MH - Humans MH - Microscopy, Atomic Force MH - Platelet Factor 4/*chemistry/*metabolism MH - Polysaccharides/metabolism MH - Protein Binding MH - Protein Structure, Secondary MH - Thermodynamics EDAT- 2014/08/26 06:00 MHDA- 2015/03/04 06:00 CRDT- 2014/08/24 06:00 PHST- 2014/08/24 06:00 [entrez] PHST- 2014/08/26 06:00 [pubmed] PHST- 2015/03/04 06:00 [medline] AID - S0006-4971(20)39718-4 [pii] AID - 10.1182/blood-2014-03-559518 [doi] PST - ppublish SO - Blood. 2014 Oct 9;124(15):2442-9. doi: 10.1182/blood-2014-03-559518. Epub 2014 Aug 22.